The AstraZeneca blood clot risk in context

Experts say odds of adverse side effect are about same as ‘being hit in your home by crashing aeroplane’

Oxford-AstraZeneca vaccine
(Image credit: Finnbarr Webster/Getty Images)

Confidence in the UK’s Covid vaccination programme risks being undermined by news that under-30s will be offered an alternative to the Oxford-AstraZeneca jab as a result of blood clot concerns, experts have warned.

Government scientists and ministers are expected to “embark on a media blitz” to persuade the public that the vaccine is still safe following the announcement by regulators, The Times reports. And media outlets have also been putting the risk into context.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More